Fig. 1From: A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocolSchematic of the study design. Exp, experimental arm; Ctr, standard of care control armBack to article page